Showing results (41-50 of 132) with videos related to

Sort By:
Pageof 14
Vaccine|June 26, 2024
"If the nurse tells me this is a good thing, I trust her completely" - Exploring health system enablers of MMR vaccine uptake in the Finnish Somali community: A mixed method studyIdil Hussein, Hodan Mohamud, Abas Hussein, et al.
Vaccine|November 4, 2008
Reactogenicity and tolerability of a non-adjuvanted 11-valent diphtheria-tetanus toxoid pneumococcal conjugate vaccine in Filipino childrenJuanita Ugpo, Marilla Lucero, Gail Williams, et al.
The Journal of Infectious Diseases|May 15, 2004
Similar antibody concentrations in Filipino infants at age 9 months, after 1 or 3 doses of an adjuvanted, 11-valent pneumococcal diphtheria/tetanus-conjugated vaccine: a randomized controlled trialMarilla G Lucero, Taneli Puumalainen, Juanita M Ugpo, et al.
Vaccine|September 12, 2022
Lower incidence of hospital-treated infections in infants under 3 months of age vaccinated with BCGHeta Nieminen, Mika Lahdenkari, Ritva K Syrjänen, et al.
Vaccine|May 12, 2009
IgG antibody concentrations after immunization with 11-valent mixed-carrier pneumococcal conjugate vaccine in efficacy trial against pneumonia among Filipino infantsAnu Soininen, Hanna Nohynek, Marilla Lucero, et al.
Emerging Microbes & Infections|June 8, 2023
Changes in SARS-CoV-2 seroprevalence and population immunity in Finland, 2020-2022Anna Solastie, Tuomo Nieminen, Nina Ekström, et al.
Vaccine|September 8, 2022
Long-term population impact of infant 10-valent pneumococcal conjugate vaccination on invasive pneumococcal disease in adults in FinlandJ Pekka Nuorti, Hanna Rinta-Kokko, Maija Toropainen, et al.
Scandinavian Journal of Infectious Diseases|November 26, 2005
Economic evaluation of pneumococcal conjugate vaccination in FinlandHeini Salo, Harri Sintonen, J Pekka Nuorti, et al.
BMJ Open|April 2, 2021
SARS-CoV-2 population-based seroprevalence studies in Europe: a scoping reviewRebecca Grant, Timothée Dub, Xanthi Andrianou, et al.
International Journal of Public Health|May 19, 2023
Incidence of SARS-CoV-2 Infection and Factors Associated With Complete COVID-19 Vaccine Uptake Among Migrant Origin Persons in FinlandKalpana Bastola, Hanna Nohynek, Eero Lilja, et al.
Pageof 14